9.40

5.26% 0.47

Anteris Technologies Global Corp (AVR)

Overview News Price History Discussions Forecast

Anteris Technologies Global Corp stock is traded at $9.40, with a volume of 683.46K. It is up +5.26% in the last 24 hours and up +5.03% over the past month. Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THV is a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.

Previous Close:

$8.93

Open:

$8.84

24h Volume:

683.46K

Relative Volume:

0.54

Market Cap:

$916.11M

Revenue:

$1.85M

Net Income/Loss:

$-95.19M

P/E Ratio:

-4.2327

EPS:

-2.2208

Net Cash Flow:

$-86.88M

1W Performance:

+5.50%

1M Performance:

+5.03%

6M Performance:

+64.62%

1Y Performance:

+139.80%

1-Day Range:

$8.725

$9.42

1-Week Range:

$8.59

$9.46

52-Week Range:

$3.30

$11.05

Anteris Technologies Global Corp Stock (AVR) Company Profile

Name

Anteris Technologies Global Corp

Sector

Healthcare (1080)

Industry

Medical Instruments & Supplies (56)

Phone

651-493-0606

Address

860 BLUE GENTIAN ROAD, EAGAN

Employee

174

Twitter

Next Earnings Date

2026-08-10

Latest SEC Filings

AVR's Discussions on Twitter

Compare AVR vs ISRG, BDX, ALC, RMD, MDLN

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AVR Anteris Technologies Global Corp	9.40	864.46M	1.85M	-95.19M	-86.88M	-2.2208
ISRG Intuitive Surgical Inc	394.51	141.76B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	183.40	50.00B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	74.25	35.57B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	224.46	32.78B	5.54B	1.52B	1.74B	10.37
MDLN Medline Inc	35.74	31.15B	29.14B	1.07B	1.05B	1.1956

Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-12-26	Resumed	Cantor Fitzgerald	Overweight
Mar-11-26	Initiated	Wells Fargo	Overweight
Jan-08-25	Initiated	Lake Street	Buy
Jan-07-25	Initiated	Barclays	Overweight
Jan-07-25	Initiated	Cantor Fitzgerald	Overweight
Jan-07-25	Initiated	TD Cowen	Buy

View All

Anteris Technologies Global Corp Stock (AVR) Latest News

Aug 14, 2026

Anteris Technologies Global (NASDAQ:AVR) Earns Overweight Rating from Cantor Fitzgerald - MarketBeat

Aug 14, 2026

Aug 13, 2026

L1 Capital Pty Ltd Expands Stake in Anteris Technologies Global Corp (AVR) with Significant Share Acquisition - GuruFocus

Aug 13, 2026

Anteris Technologies Global Corp. (ASX:AVR) Share Price Falls 4.05% as Stock Trades Within Daily Range - Kalkine

Aug 13, 2026

Aug 12, 2026

Anteris Technologies Global (NASDAQ:AVR) Shares Down 4.3% Following Weak Earnings - MarketBeat

Aug 12, 2026

L1 Capital Executes Two-Day Sale of Over 627,000 Anteris Technologies Shares - Kalkine Media

Aug 12, 2026

Anteris Technologies Global (NASDAQ:AVR) Major Shareholder L1 Capital Pty Ltd Sells 251,844 Shares of Stock - MarketBeat

Aug 12, 2026

L1 Capital Pty Ltd Sells 375,815 Shares of Anteris Technologies Global (NASDAQ:AVR) Stock - MarketBeat

Aug 12, 2026

L1 Capital (AVR) reports 627,659-share sale and sizable CDI, warrant stakes - Stock Titan

Aug 12, 2026

Assenagon Asset Management S.A. Invests $6.35 Million in Anteris Technologies Global Corp. $AVR - MarketBeat

Aug 12, 2026

Anteris Technologies Q2 Loss Narrows, Net Sales Rise - marketscreener.com

Aug 12, 2026

Aug 11, 2026

Why Is Anteris Technologies Global (ASX:AVR) Drawing Fresh Attention Among ASX Healthcare Stocks? - Kalkine Media

Aug 11, 2026

L1 Capital Pty Ltd Trims Anteris Technologies Global Corp (AVR) Stake Amid Strong Rally - GuruFocus

Aug 11, 2026

Anteris Technologies Q2 loss widens, sales miss estimates - scanx.trade

Aug 11, 2026

Anteris Technologies Reports Q2 2026 Results With PARADIGM Trial Expansion and U.S. Medicare Reimbursement Secured - Kalkine

Aug 11, 2026

Anteris Technologies advances PARADIGM Trial in June quarter as US patient recruitment gets underway - Proactive financial news

Aug 11, 2026

Anteris Technologies Q2 Loss Narrows, Net Sales Up - marketscreener.com

Aug 11, 2026

Anteris Technologies Announces Results for the Second Quarter of 2026 - Yahoo Finance

Aug 11, 2026

Anteris Technologies Global Corp reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 11, 2026

Anteris Technologies Announces Q2 2026 Financial Results Highlighting Increased R&D Expenses - Kalkine Media

Aug 11, 2026

Anteris Technologies Global (NASDAQ:AVR) Releases Earnings Results, Misses Estimates By $0.09 EPS - MarketBeat

Aug 11, 2026

Anteris Technologies (AVR) boosts cash to $260.9M while losses mount in DurAVR valve push - Stock Titan

Aug 11, 2026

Anteris Technologies Global Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 11, 2026

Anteris Technologies Global Corp. (ASX:AVR) Updates Market on Court Orders and CDI Matter Resolution - Kalkine

Aug 11, 2026

Aug 10, 2026

L1 Capital Pty Ltd Trims Anteris Technologies Global Corp (AVR) Stake - GuruFocus

Aug 10, 2026

L1 Capital Reports Sale of 174,721 Anteris Technologies Shares at $8.10 Each - Kalkine Media

Aug 10, 2026

Anteris Technologies Global (NASDAQ:AVR) Major Shareholder Sells $1,415,240.10 in Stock - MarketBeat

Aug 10, 2026

L1 Capital (AVR) trims Anteris stake, retains 5.44M shares and CDI warrants - Stock Titan

Aug 10, 2026

Aug 09, 2026